Vitamin E Formulation for Biofilm Disruption on Sensitive Skin
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for biofilm-related infections are hindered by the intrinsic resistance of biofilms to antimicrobial drugs and host defenses, making it difficult to diagnose, treat, and prevent infections, especially on sensitive skin.
Innovation Solution
A topical formulation comprising vitamin E or its ester, such as alpha-tocopheryl acetate, combined with volatile silicone and hydrogenated castor oil, effectively reduces or inhibits bacterial and fungal biofilm formation without causing allergic reactions, suitable for sensitive skin.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antimicrobial drugs are used to treat biofilm-related infections, then the treatment approach is standard and simple, but the drugs are intrinsically resistant and ineffective against biofilms
Solution Approach 1:
The patent changes the chemical parameter of the treatment by using vitamin E and its esters instead of conventional antimicrobial drugs. This parameter change allows the treatment to penetrate and disrupt the biofilm matrix, overcoming the intrinsic resistance that prevents conventional drugs from working effectively on biofilm-related infections.
Solution Approach 2:
The patent employs composite formulations combining vitamin E with its esters (such as tocopheryl acetate, tocopheryl palmitate) and optionally with carriers or adjuvants. This composite approach enhances the ability to disrupt biofilm structure while maintaining stability and effectiveness, addressing the resistance issue that single-agent conventional treatments cannot overcome.
2Reliability
If strong antimicrobial agents are used to eradicate biofilms, then the biofilm resistance is overcome, but the skin becomes sensitive and intolerant due to allergic reactions
Solution Approach 1:
The patent uses vitamin E and its esters, which are naturally occurring, biocompatible compounds that can be safely applied topically. These substances provide effective biofilm disruption without the harsh side effects of strong synthetic antimicrobials, allowing repeated application on sensitive skin without causing allergic reactions or intolerance.
Solution Approach 2:
Vitamin E and its esters act as intermediary substances that mediate between the need for effective biofilm eradication and the requirement for skin safety. They provide a bridge that allows antimicrobial action against biofilms while maintaining compatibility with sensitive, intolerant, or allergy-prone skin, avoiding the extreme harshness of conventional strong antimicrobials.
3Object-affected harmful factors
If topical formulations are applied to sensitive skin, then skin tolerance is maintained, but the formulation lacks effectiveness against resistant biofilms
Solution Approach 1:
The patent changes the chemical composition parameters of topical formulations by incorporating vitamin E and its esters at optimized concentrations. This parameter optimization enables the formulation to maintain skin tolerance while simultaneously achieving effective biofilm disruption, overcoming the limitation of conventional gentle formulations that lack anti-biofilm activity.
Solution Approach 2:
The patent creates composite topical formulations combining vitamin E with its esters and potentially with carriers or adjuvants. This composite structure provides both the gentleness required for sensitive skin and the enhanced biofilm-disrupting capability needed to overcome resistance, achieving a balance that single-component formulations cannot provide.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation significantly reduces biofilm production by 50-86% on various microbial strains, demonstrating its effectiveness in inhibiting biofilm formation and providing a safe option for sensitive skin applications.
Implementation Method 1
a formulation for topical use consisting of vitamin E or an ester thereof for a therapeutic use in removing, reducing or inhibiting a bacterial and/or fungal biofilm
Implementation Method 2
The formulation significantly reduces biofilm production by 50-86% on various microbial strains, demonstrating its effectiveness in inhibiting biofilm formation
Data Source
Figure 1
Figure 2
AI summary
Formulation for topical use based on vitamin E or an ester thereof for use in removing, reducing or inhibiting a bacterial and/ or fungal biofilm, wherein said ester of vitamin E is an ester with a carboxylic acid of formula R-COOH, in which R is an alkyl radical having from 1 to 19 carbon atoms, or an alkenyl or alkynyl having from 2 to 19 carbon atoms.